Dr. Andre E. Manov is a highly accomplished medical professional with extensive experience in internal medicine, endocrinology, medical education, and leadership. He currently serves as the Program Director for the Transitional Residency Program at Sunrise Health GME, Mountain View Hospital in Las Vegas, Nevada. In addition to this role, he is the Associate Program Director for the Internal Medicine Residency Program at the same institution, where he has been an integral part of the faculty since 2020. Dr. Manov also holds the position of Director of the Medicine Clinic at Mountain View Hospital, where he continues to make significant contributions to patient care.
Dr. Manov has a long history of academic involvement, serving as a Clinical Professor at several esteemed institutions, including the University of Las Vegas, Nevada, and the University of Nevada, Reno School of Medicine. He has been a prominent figure in medical education, having taught and mentored countless medical students, residents, and fellows throughout his career. His leadership roles have included serving as the Chairman of the Department of Internal Medicine at John Peter Smith (JPS) Health Network in Fort Worth, Texas, from 2008 to 2018, where he successfully managed over 100 physicians and helped shape the internal medicine program.
Throughout his career, Dr. Manov has maintained board certifications in Endocrinology, Diabetes, and Metabolism, as well as in Internal Medicine. His clinical expertise has been invaluable, particularly in the care of patients with endocrine emergencies and complex internal medicine conditions. He has also been involved in numerous educational programs, including serving as the Endocrinology Sub-Specialty Educational Coordinator and Course Director for Medical Students at various institutions.
Dr. Manov's contributions to medical education and clinical practice are complemented by his extensive experience in research, leadership, and teaching, making him a highly respected figure in the field of internal medicine and endocrinology.
Endocrinology, diabetes, and metabolism, with a strong emphasis on medical education and residency training. He is particularly dedicated to improving clinical outcomes and educational strategies in internal medicine.
Can Continuous Glucose Monitoring be Successful in Managing Diabetes Mellitus in the General Internal Medicine Residency Clinic-Extension Trial?
The goal of our 4-year retrospective extension study was to find out if continuous glucose monitoring( CGM) can be safely introduced in an Internal medicine Residency clinic and not only a specialized Endocrine clinic for the management of Diabetes Mellitus( DM) type 1 and Type 2 who were using 3-4 injections of Insulin per day and self-monitored their blood glucose(SMBG) 4 times a day. We monitored 91- patients who SMBG 4- times a day and were given by our Internal medicine Residents CGM devices to monitor their blood glucose because of their uncontrolled diabetes. The residents functioned under the supervision of a Board-certified endocrinologist who was a member of the clinic. The residents were in contact with the assigned patients by phone every 2- weeks and were adjusting the patients’ treatment. Also, the patients were seen every 2- months by members of the CGM team in the clinic. The CGM team consulted with the endocrinologist whenever needed to ensure excellent treatment of patients’ diabetes.
We achieved a reduction of HbA1c from 10.4% to 7.043% and 58% of this reduction- 1.9% was achieved in the first 3 months of the study. The average blood glucose decreased from 250 mg/dl to 154 mg/dl, reduction of the incidence of mild hypoglycemia below 70 mg/dl to 54 mg/dl from 4.1% to 0.264% per day, and more pronounced hypoglycemia with glucose less than 54 mg/dl from 1.1% per day to 0.187% per day. We observed a significant increment in the time in the blood glucose range from 18% to 63% per day. Furthermore, 10% of the patients in this study eventually discontinued their daily insulin injections and continued treatment with oral diabetic medications with or without the use of injectable GLP-1 receptors once a week.
Our study adds to the excellent improvement of glucose control in managing DM by using CGM data instead of SMBG in the most difficult-to-treat patients with DM using multiple insulin injections per day. These excellent results confirm and add to the existing data that nationwide usage in internal medicine residency programs of CGM can be introduced to improve the quality of treatment of patients with DM and the education of residents in general internal medicine residency clinics in the USA.